{"transactions":[{"id":823120,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":2992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's adjusted earnings per share (EPS) for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's adjusted earnings per share (EPS) for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2992,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2992},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823119,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":2992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2026 and ending December 31, 2028 relative to the total shareholder return of an index of companies, as determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F14","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2026 and ending December 31, 2028 relative to the total shareholder return of an index of companies, as determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2992,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2992},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823118,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":2992,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's revenue growth for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's revenue growth for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2992,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2992},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823117,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"grant","planned":false,"acquired":true,"shares":8976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"On March 30, 2026, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Second A&R 2022 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"On March 30, 2026, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Second A&R 2022 Plan) and the award agreement."}],"balance_after":8976,"derivative":{"underlying":"Ordinary Shares","underlying_shares":8976},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823116,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":6057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2023 and ending December 31, 2025 relative to the total shareholder return of an index of companies, as determined by the 2022 Plan Administrator. The Company has determined that 113.89% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 113.89%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2023 and ending December 31, 2025 relative to the total shareholder return of an index of companies, as determined by the 2022 Plan Administrator. The Company has determined that 113.89% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 113.89%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6057},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823115,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":3156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's Return on Investment Capital (ROIC) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 118.71% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 118.71%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's Return on Investment Capital (ROIC) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 118.71% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 118.71%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3156},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823114,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":3243,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3243},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823113,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":2343,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement."}],"balance_after":4684,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2343},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823112,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":2457,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1229},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823111,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."}],"balance_after":1329,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1330},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823110,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":false,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":457},"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823109,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":8377,"price":61.27,"value":513258.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":22189,"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":823108,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2026-04-01T17:20:06.000Z","date":"2026-03-30","kind":"exercise","planned":false,"acquired":true,"shares":17815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":30566,"source":{"system":"sec-edgar","filing":"0001639691-26-000023","document":"wk-form4_1775078403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969126000023/wk-form4_1775078403.xml","form_type":"4"}},{"id":1186708,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Stock Appreciation Rights","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":15385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"On March 30, 2025, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the Plan and the award agreement."}],"balance_after":15385,"derivative":{"exercise_price":39.13,"expiration_date":"2035-03-30","underlying":"Ordinary Shares","underlying_shares":15385},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186707,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":7027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on the Company's TSR for the three-year period beginning on January 1, 2025 and ending December 31, 2027 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":7027,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7027},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186706,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":3513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's ROIC calculated for the performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":3513,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3513},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186705,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":3513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"On March 30, 2025, reporting person was granted PSUs to vest or lapse on March 30, 2028 based on how the Company's FCF for performance period 2025-2027 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":3513,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3513},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186704,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":7027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award\nagreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":7027,"derivative":{"underlying":"Ordinary Shares","underlying_shares":7027},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186703,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1060,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's total shareholder return (TSR) for the three-year period beginning on January 1, 2022 and ending December 31, 2024 relative to the total shareholder return of a peer group of companies, as determined by the 2015 Plan Administrator. The Company's performance achieved a result of 58%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1060},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186702,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":717,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's Return on Investment Capital (ROIC) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The performance achieved was 78.5%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":717},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186701,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On March 30, 2022, reporting person was granted PSUs to vest or lapse on March 30, 2025 based on the Company's cumulative adjusted free cash flow (FCF) for performance period 2022-2024 compared to a target determined by the 2015 Plan Administrator. The Company has determined that 88.1% of the underlying PSUs shall vest on March 30, 2025, subject to continued service during the vesting period and the award agreement. The performance achieved was 88.1%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":805},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186700,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award\nagreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":3686,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1229},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186699,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award\nagreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":2659,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1330},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186698,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award\nagreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to\nforfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to\nforfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":457,"derivative":{"underlying":"Ordinary Shares","underlying_shares":457},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186697,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":false,"shares":426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award\nagreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to\nforfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 30, 2021, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2022. The RSUs are subject to\nforfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":426},"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186696,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2835,"price":39.13,"value":110933.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld to satisfy tax liability."}],"balance_after":12751,"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1186695,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2025-04-01T21:01:28.000Z","date":"2025-03-30","kind":"exercise","planned":false,"acquired":true,"shares":6024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value."}],"balance_after":15586,"source":{"system":"sec-edgar","filing":"0001639691-25-000029","document":"wk-form4_1743555682.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969125000029/wk-form4_1743555682.xml","form_type":"4"}},{"id":1554082,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Stock Appreciation Rights","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"grant","planned":false,"acquired":true,"shares":10746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F18","text":"On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F18","text":"On March 30, 2024, reporting person was granted stock appreciation rights (SARs) subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The SARs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":10746,"derivative":{"exercise_price":55.94,"underlying":"Ordinary Shares","underlying_shares":10746},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554081,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"grant","planned":false,"acquired":true,"shares":4915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F17","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on the Company's TSR for the three-year period beginning on January 1, 2024 and ending December 31, 2026 relative to the TSR of an index of companies, as determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":4915,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4915},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554080,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"grant","planned":false,"acquired":true,"shares":2457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F16","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's ROIC calculated for the performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2457,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2457},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554079,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"grant","planned":false,"acquired":true,"shares":2457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F14","text":"Each performance stock unit (PSU) represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F15","text":"On March 30, 2024, reporting person was granted PSUs to vest or lapse on March 30, 2027 based on how the Company's FCF for performance period 2024-2026 compares to a target determined by the 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement."}],"balance_after":2457,"derivative":{"underlying":"Ordinary Shares","underlying_shares":2457},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554078,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"grant","planned":false,"acquired":true,"shares":4915,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one Ordinary Share, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting occurring on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":4915,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4915},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554077,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1961,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"On March 30, 2021, the reporting person was granted 1,706 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F12","text":"On March 30, 2021, the reporting person was granted 1,706 PSUs. The vesting of the PSUs depended on the Company's performance against a target of the total shareholder return (TSR) for fiscal years 2021, 2022, and 2023, compared to peer companies. The Company's performance achieved a result of 115%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1961},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554076,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1290,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F11","text":"On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's Return on Investment Capital (ROIC) for fiscal year 2021 with additional two years service condition. The performance achieved was 151.30%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1290},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554075,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Performance Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"Each PSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the 2015 Plan and the terms of the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal year 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"On March 30, 2021, the reporting person received a grant of 853 PSUs. The number of PSUs that vested was the result of the Company's performance against a target related to Free Cash Flow (FCF) for fiscal year 2021 with additional two years service condition. The performance achieved was 200%, and the actual number of vested shares is presented as the quantity that was acquired."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554074,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":1330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each RSU represents a contingent right to receive one Ordinary Share, in accordance with the terms of the LivaNova PLC 2022 Incentive Award Plan (the 2022 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The reporting person was granted 5,319 RSUs on March 30, 2023, subject to a four-year vesting in equal annual installments, which began on March 30, 2024. The unvested RSUs reported here vest 25% on March 30, 2025, March 30, 2026, and March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"The reporting person was granted 5,319 RSUs on March 30, 2023, subject to a four-year vesting in equal annual installments, which began on March 30, 2024. The unvested RSUs reported here vest 25% on March 30, 2025, March 30, 2026, and March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement."}],"balance_after":3989,"derivative":{"underlying":"Ordinary Shares","underlying_shares":1330},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554073,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The reporting person was granted 1,828 RSUs on March 30, 2022, subject to a four-year vesting in equal annual installments, which began on March 30, 2023. The remaining unvested RSUs reported here vest 25% on March 30, 2025 and March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The reporting person was granted 1,828 RSUs on March 30, 2022, subject to a four-year vesting in equal annual installments, which began on March 30, 2023. The remaining unvested RSUs reported here vest 25% on March 30, 2025 and March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":914,"derivative":{"underlying":"Ordinary Shares","underlying_shares":457},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554072,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 1,706 RSUs on March 30, 2021, subject to a four-year vesting in equal annual installments, which began on March 30, 2022. The remaining unvested RSUs reported here vest 25% on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The reporting person was granted 1,706 RSUs on March 30, 2021, subject to a four-year vesting in equal annual installments, which began on March 30, 2022. The remaining unvested RSUs reported here vest 25% on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":426,"derivative":{"underlying":"Ordinary Shares","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554071,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Restricted Stock Units","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":false,"shares":573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one Ordinary Share of the Company in accordance with the terms of the LivaNova PLC 2015 Incentive Award Plan (the 2015 Plan) and the award agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 2,295 RSUs on March 30, 2020, subject to a four-year vesting in equal annual installments, which began on March 30, 2021. RSUs reported here vested 25% on March 30, 2024. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The reporting person was granted 2,295 RSUs on March 30, 2020, subject to a four-year vesting in equal annual installments, which began on March 30, 2021. RSUs reported here vested 25% on March 30, 2024. The RSUs were subject to forfeiture prior to vesting in accordance with the terms of the 2015 Plan and the award agreement."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":573},"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554070,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3643,"price":55.94,"value":203789.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The referenced shares were withheld from distribution to satisfy tax liability."}],"balance_after":9562,"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}},{"id":1554069,"issuer":{"id":507,"kind":"organization","name":"LivaNova PLC","symbol":"LIVN"},"owners":[{"id":54732,"kind":"person","name":"Bolton Stephanie","position":1,"cik":"0002012558","reported_name":"Bolton Stephanie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Global Epilepsy"}}],"security":"Ordinary Shares","published_at":"2024-04-02T21:22:38.000Z","date":"2024-03-30","kind":"exercise","planned":false,"acquired":true,"shares":7744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting person had vested restricted stock units (RSUs) and performance stock units (PSUs) settled in Ordinary Shares of LivaNova PLC (the Company)."}],"balance_after":13205,"source":{"system":"sec-edgar","filing":"0001639691-24-000049","document":"wk-form4_1712107347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2012558/000163969124000049/wk-form4_1712107347.xml","form_type":"4"}}]}